TGTX
TG Therapeutics Inc
57.40$
-0.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -115.8% | – | – | -320.5% | – | – | – | -411.4% | – | -191.0% | – | – | |
| – | -27.8% | -9.9% | -12.2% | -11.1% | -3.1% | -9.7% | +5.4% | +5.1% | +12,033.9% | -98.9% | +6.3% | – | |
| – | +2.2% | -0.5% | +1.5% | +24.2% | +1.5% | +25.3% | +9.3% | +8.1% | -11.5% | +27.5% | +139.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -12.5% | +19.0% | +68.0% | +90.5% | -16.2% | -23.9% | +574.5% | – | |
| – | +48.1% | -79.3% | – | -628.8% | – | -181.9% | -69.1% | – | -133.7% | -36.9% | -10.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -100.0% | – | +214,800.0% | +207.6% | -7.4% | +12.3% | +1,038.1% | -75.6% | +422.9% | +0.0% | – | |
| – | – | – | – | – | -100.0% | – | – | – | – | – | -100.0% | – | |
| – | -100.2% | – | +1,250.0% | +99,495.6% | -104.5% | +0.5% | +5.6% | +1,114.4% | – | +36,840.4% | +0.0% | – | |
| – | -207.6% | – | – | +1,419.1% | -114.1% | – | – | – | – | +7,046.9% | +11.1% | – | |
| – | -115.8% | – | – | -320.9% | – | – | – | -414.2% | – | -191.6% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.